Given our finding that subcutaneous injection of tumour cells into mice simultaneously with human proangiogenic monocytes boosted the development of the colon carcinomas DLD1 and HCT116 but not the breast carcinoma SKBR7, we investigated whether tumour cell-derived inhibitors would block MMP9. This evidence concerns the gene MMP9 and colon carcinoma.